Park City Group, Inc. operates as a Software-as-
************************************************
Power3 Medical Products, Inc. (OTC.BB:PWRM)
Alzheimer’s doesn’t have any immediate cure, but remedies for indicators can be found and investigate carries on. Even though current Alzheimer treatment options cannot cease Alzheimer’s disease from progressing, they’re able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer’s disease as well as all their caregivers.
Breast cancer (malignant breast neoplasm) is cancer originating from breast tissue, most frequently belonging to the inner lining of milk ducts as well as lobules that offer the ducts with milk. Cancers originating from ducts are known as ductal carcinomas; those originating from lobules are classified as lobular carcinomas.
Parkinson’s disease (PD) is part of a team of ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
************************************************
GreenHouse Holdings, Inc. (OTCQB:GRHU)
GreenHouse estimates that the projects will generate $500,000 in revenue to the company. This projection is based upon approximately 1,500 kW or 1.5 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
The Auto-DR program offers significant financial incentives and technical support to Southern California Edison (SCE) customers willing to install equipment that enables participation in demand response events versus depending on their employees to perform all the curtailment activities manually when required. Normally, control systems (automation)
GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products.
************************************************
Invesco announced that a Notice of Pendency of Derivative Action and Hearing on Proposed Settlement is available for viewing by shareholders of Invesco High Yield Investments Fund, Inc. (NYSE:MSY) at www.invesco.com/
Invesco is a leading independent global investment manager, dedicated to helping investors worldwide achieve their financial objectives.
************************************************
LSI Corporation (NYSE:LSI) announced that the LSI SAS6160 switch has been selected as a finalist for the 2010 Storage magazine/SearchStorage.com Products of the Year Awards.
LSI Corporation designs, develops, and markets storage and networking semiconductors and storage systems. Its Semiconductor segment offers integrated circuits for hard disk and tape drive solutions, including systems-on-a-
***************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/



